Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling

The Androgen Receptor (AR) has recently garnered a lot of attention as a potential biomarker and therapeutic target in hormone-dependent cancers, including breast cancer. However, several inconsistencies exist within the literature as to which subtypes of breast cancer express AR or whether it can b...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Zahrani, Khalid N., Cook, David P., Vanderhyden, Barbara C., Sabourin, Luc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161783/
https://www.ncbi.nlm.nih.gov/pubmed/30279965
http://dx.doi.org/10.18632/oncotarget.26072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161783/
https://www.ncbi.nlm.nih.gov/pubmed/30279965
http://dx.doi.org/10.18632/oncotarget.26072

Ejemplares similares